Terri B. Sebree

2022

In 2022, Terri B. Sebree earned a total compensation of $1.4M as President at Zynerba Pharmaceuticals, a 14% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$225,710
Option Awards$242,413
Salary$486,236
Stock Awards$409,700
Other$17,204
Total$1,381,263

Sebree received $486.2K in salary, accounting for 35% of the total pay in 2022.

Sebree also received $225.7K in non-equity incentive plan, $242.4K in option awards, $409.7K in stock awards and $17.2K in other compensation.

Rankings

In 2022, Terri B. Sebree's compensation ranked 2,401st out of 5,753 executives tracked by ExecPay. In other words, Sebree earned more than 58.3% of executives.

ClassificationRankingPercentile
All
2,401
out of 5,753
58th
Division
Manufacturing
1,322
out of 3,133
58th
Major group
Chemicals And Allied Products
591
out of 1,419
58th
Industry group
Drugs
546
out of 1,320
59th
Industry
Pharmaceutical Preparations
395
out of 966
59th
Source: SEC filing on April 21, 2023.

Sebree's colleagues

We found two more compensation records of executives who worked with Terri B. Sebree at Zynerba Pharmaceuticals in 2022.

2022

Armando Anido

Zynerba Pharmaceuticals

Chief Executive Officer

2022

James Fickenscher

Zynerba Pharmaceuticals

Chief Financial Officer

News

You may also like